The antibody immune response is essential for the survival of mammals. However, we still
lack a systematic understanding of the antibody repertoire. Here, we developed a proteomic …

The COVID-19 (coronavirus disease-19) pandemic affected more than 180 million people
around the globe, causing more than five million deaths as of January 2022. SARS-CoV-2 …

The article describes the rationale for the administration of zinc-chelating agents in COVID-
19 patients. In a previous work I have highlighted that the binding of the SARS-CoV spike …

D‐peptide ligands can be screened for therapeutic potency and enzymatic stability using
synthetic mirror‐image proteins (D‐proteins), but efficient acquisition of these D‐proteins …

COVID-19 pandemic is a global public health emergency. Despite extensive research, there
are still few effective treatment options available today. Neutralizing-antibody-based …

Exposure to severe acute respiratory syndrome-corona virus-2 (SARS-CoV-2) prompts
humoral immune responses in the human body. As the auxiliary diagnosis of a current …

As global vaccination campaigns against SARS-CoV-2 proceed, there is particular interest
in the longevity of immune protection, especially with regard to increasingly infectious virus …

The outbreak of coronavirus disease 2019 (COVID-19) has not only affected human health
but also diverted the focus of research and derailed the world economy over the past year …

Abstract Background Since December 2019, the newly emerged SARS-CoV-2 virus
continues to infect humans and many people died from severe Covid-19 during the last 2 …

One of the most pressing challenges associated with SARS-CoV-2 treatment is the
emergence of new variants that may be more transmissible, cause more severe disease, or …